NXGL

Nexgel Inc

NXGL.US nexgel.com + Research + Basket
CIK 0001468929
Employees 19
Phone 215 702 8550
Fiscal year end December
IPO Dec 22, 2021
Address 2150 Cabot Boulevard West, Langhorne, PA, United States, 19047
4.01
-0.47 (-10.49%)
USD · NASDAQ
52-week range
3.00
53.60
Trading at 2% of the 52-week range
Market Cap
2.18M
P/E Ratio
0.00
Forward P/E
1.38
Book Value
10.20
Div. Yield
N/A
% Institutions
13.88%
% Insiders
14.02%

1 Year

-90.9%

3 Year

-89.3%

10 Year

-94.3%
Description

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Actions

Add an action for NXGL.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Brian J. Kieser CPA Interim CEO & Director 1967
Mr. Ian Blackman CPA Chief Financial Officer 1968
Mr. Gregory J. Robb Vice President of Operations NA
Mr. Valter Pinto Managing Director of KCSA Strategic Communications NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 24, 2025 Adam R Levy N/A Sale 4.00K $1.57 $6.28K SEC
Dec 22, 2025 Adam R Levy N/A Sale 6.00K $1.61 $9.66K SEC
Nov 06, 2025 Adam R Levy N/A Sale 4.00K $2.52 $10.08K SEC
Oct 03, 2025 Adam R Levy N/A Sale 2.40K $2.55 $6.12K SEC
Oct 03, 2025 Scott Robert Henry N/A Sale 7.18K $2.55 $18.30K SEC
Oct 02, 2025 Adam R Levy N/A Sale 1.60K $2.50 $4.00K SEC
Oct 02, 2025 Scott Robert Henry N/A Sale 825.00 $2.50 $2.06K SEC
Sep 25, 2025 Scott Robert Henry N/A Sale 7.70K $2.36 $18.16K SEC
Aug 28, 2025 Adam R Levy N/A Sale 4.00K $2.47 $9.88K SEC
Jun 13, 2025 Scott Robert Henry N/A Sale 3.00K $2.57 $7.71K SEC
Jun 11, 2025 Adam R Levy N/A Sale 2.00K $2.39 $4.78K SEC
Jun 09, 2025 Adam R Levy N/A Sale 2.00K $2.33 $4.66K SEC
Jun 04, 2025 Adam R Levy N/A Sale 1.00K $2.29 $2.29K SEC
May 30, 2025 Adam R Levy N/A Sale 1.00K $2.22 $2.22K SEC
May 16, 2025 Adam R Levy N/A Sale 1.00K $2.58 $2.58K SEC
May 12, 2025 Scott Robert Henry N/A Sale 3.00K $2.69 $8.07K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Susquehanna International Group, LLP 85.14K Jun 30, 2026 0.87% $0.00 0.00%
Virtu Financial LLC 79.13K Jun 30, 2026 0.81% $0.00 0.00%
Geode Capital Management, LLC 71.86K Jun 30, 2026 0.74% $0.00 -44.09%
HRT FINANCIAL LLC 69.49K Jun 30, 2026 0.71% $0.00 348.41%
Morgan Stanley - Brokerage Accounts 54.98K Jun 30, 2026 0.56% $0.00 0.00%
Vanguard Capital Management, LLC 48.92K Jun 30, 2026 0.50% $0.00 0.00%
Citadel Advisors Llc 40.98K Jun 30, 2026 0.42% $0.00 0.00%
Vanguard Fiduciary Trust Co 34.04K Jun 30, 2026 0.35% $0.00 0.00%
UBS Group AG 24.74K Jun 30, 2026 0.25% $0.00 272.85%
Jane Street Group LLC 20.61K Jun 30, 2026 0.21% $0.00 -51.10%
State Street Corp 17.26K Jun 30, 2026 0.18% $0.00 0.00%
Northern Trust Corp 13.43K Jun 30, 2026 0.14% $0.00 0.00%
Hbk Sorce Advisory LLC 12.50K Jun 30, 2026 0.13% $0.00 0.00%
Ground Swell Capital, LLC 11.20K Jun 30, 2026 0.11% $0.01 0.00%
Tower Research Capital LLC 2.16K Jun 30, 2026 0.02% $0.00 0.00%
Citigroup Inc 1.14K Jun 30, 2026 0.01% $0.00 0.00%
Advisor Group Holdings, Inc. 305.00 Jun 30, 2026 0.00% $0.00 0.00%
Royal Bank of Canada 32.00 Jun 30, 2026 0.00% $0.00 0.00%
SBI Securities Co Ltd 7.00 Jun 30, 2026 0.00% $0.00 0.00%
FLAX POND CAPITAL, LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 44.56K 0.46% ▲ 0.00% Aug 31, 2026
2 Fidelity Total Market Index 13.58K 0.14% ▲ 0.00% Aug 31, 2026
3 Fidelity Series Total Market Index 8.68K 0.09% ▲ 0.00% Aug 31, 2026
4 Fidelity Nasdaq Composite Index 546.00 0.01% ▲ 0.00% Aug 31, 2026
5 DFA US Micro Cap I 198.00 0.00% ▲ 0.00% Aug 31, 2026
6 DFA US Small Cap I 152.00 0.00% ▲ 0.00% Aug 31, 2026
7 Dimensional US Small Cap ETF 144.00 0.00% ▲ 0.00% Oct 02, 2026

Financial Highlights

▼
Market Cap: $2.18M
EBITDA: $-4.25M
Book Value: $10.20
Earnings/Share: $-14.80
Profit Margin: -51.26%
Operating Margin: -67.96%
ROA (TTM): -18.68%
ROE (TTM): -115.07%
Revenue (TTM): $12.07M
Revenue/Share (TTM): $29.17
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 27.80%

Valuation Metrics

Enterprise Value: $8.81M
Trailing P/E: 0.00
Forward P/E: 1.38

Shares Statistics

Shares Outstanding: 487.38K
Shares Float: 383.89K
% Insiders: 14.02%
% Institutions: 13.88%
Shares Short: 104.74K
Shares Short (Prior Month): 322.45K
Short Ratio: 0.50
Short % Float: 25.00%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$11.42M
Cost of Goods Sold
adjust
$-6.91M
Gross Profit
subtotal
$4.51M
SG&A
adjust
$-7.86M
R&D
adjust
$-2.00K
Operating Income
subtotal
$-3.35M
Other / Non-Operating Items
adjust
$352.00K
Net Income
subtotal
$-3.00M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NXGL.US!